Med Mycol

• 

  Publication Venue For

  • Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort..  59:392-399. 2021
  • Assessing the virulence of Cryptococcus neoformans causing meningitis in HIV infected and uninfected patients in Vietnam..  58:1149-1161. 2020
  • Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda..  58:569-578. 2020
  • Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem..  55:278-284. 2017
  • Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)..  53:440-446. 2015
  • Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory..  52:537-545. 2014
  • Role of autophagy genetic variants for the risk of Candida infections..  52:333-341. 2014
  • Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort..  51:568-575. 2013
  • Human genetic susceptibility to Candida infections..  50:785-794. 2012
  • Risk factors for mortality in patients with mucormycosis..  50:611-618. 2012
  • Regulation of expression, activity and localization of fungal chitin synthases..  50:2-17. 2012
  • Heterothallic mating in Mucor irregularis and first isolate of the species outside of Asia..  49:714-723. 2011
  • Overview of treatment options for invasive fungal infections..  49:561-580. 2011
  • Newer combination antifungal therapies for invasive aspergillosis..  49 Suppl 1:S77-S81. 2011
  • Early treatment of candidemia in adults: a review..  49:113-120. 2011
  • Cutaneous cryptococcosis in solid organ transplant recipients..  48:785-791. 2010
  • Surfactant protein D binding to Aspergillus fumigatus hyphae is calcineurin-sensitive..  48:580-588. 2010
  • Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis..  47 Suppl 1:S355-S361. 2009
  • Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii..  47:561-570. 2009
  • Invasive mould infections: a multi-disciplinary update..  47:571-583. 2009
  • Combination antifungal therapy for invasive aspergillosis - Is it indicated?.  44:S373-S382. 2006
  • Host genetics affect susceptibility to invasive aspergillosis..  44:S55-S60. 2006